Frost & Sullivan: Clinical Trial-based Evidence Vital to Obtain Venture Capital Funding for Wireless Patient Monitoring Technologies

MOUNTAIN VIEW, Calif., Feb. 14, 2013 /PRNewswire/ -- Wireless patient monitoring (WPM) technology is attracting the interest of market majors as well as a significant number of start-ups. Venture capitalists (VCs) are showing keen interest in the disruptive WPM technology and will play a major role in bringing it to market.

New analysis from Frost & Sullivan's (http://www.technicalinsights.frost.com) Wireless Patient Monitoring Technologies—Evaluation of Funding Prospects research finds that information and communication technologies (ICT) play a major role in placing WPM technologies within consumers' reach. VCs realize the WPM market offers long-term returns; however, the lack of standards in interoperability may delay the scaling up of WPM technologies.

If you are interested in more information on this research, please email Britni Myers, Corporate Communications, at [email protected], with your full name, company name, job title, telephone number, company email address, company website, city, state and country.

"Investment funding in WPM technologies have increased, mainly due to an aging population and a consequent rise in the incidence of chronic diseases," notes Technical Insights Industry Analyst Saju John Mathew. "There is a growing need to manage patients in remote locations, as hospital costs are escalating and the ratio of physicians to patients is skewed."

WPM is not only a convenient tool for elderly patients to monitor their day-to-day health, but the technology also helps the government and end users reduce healthcare expenditure. Therefore, the government needs to encourage reimbursement for healthcare that employs WPM, or else end users may be reluctant to adopt this technology. Similarly, the irregular and diverse safety regulations across different geographies could hinder widespread technology adoption.

Another major hurdle to the global uptake of WPM technology is the digital divide between the developed and developing countries. The lack of standardization of wireless data interfacing sensors and monitoring devices needs attention as soon as possible. Standardization among the different entities in the WPM market is necessary to improve interoperability among devices, choice of system assembly, and other related services.

Additionally, WPM companies need to back their technology with strong evidence-based clinical trials. It is important to document the technology's effectiveness, as investors need documented proof before investing.

"The WPM market needs to increasingly integrate evidence-based clinical trials and routine adoption of outcome measures as part of patient assessment," noted Mathew. "The pool of strong, positive data accumulated will encourage VCs to invest in WPM technologies."

The WPM system should have a simple user interface, be cost effective, and adhere to Health Insurance Portability and Accountability Act (HIPAA) laws for maintaining data security and health information confidentiality. Participants are also working toward providing an integrated suite of technologies including sensors, wireless infrastructure, user-friendly workflow process, collection of data in a central repository, and data analytics to use the accrued data to attract more investments.

Connect with Frost & Sullivan on social media, including Twitter, Facebook, SlideShare, and LinkedIn, for the latest news and updates.

Wireless Patient Monitoring Technologies—Evaluation of Funding Prospects, a part of the Technical Insights subscription, evaluates the funding prospects of the WPM market. It analyzes the prevalent investor climate in this industry and the different channels available for obtaining funds. In this research, Frost & Sullivan's expert analysts thoroughly examine the prospects of obtaining funds from venture capital, investors, government grants, and smart scouting. Further, this research service includes detailed technology analysis and industry trends evaluated following extensive interviews with market participants.

Technical Insights is an international technology analysis business that produces a variety of technical news alerts, newsletters and research services.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

• The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
• The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on "the next big thing"

Register:         Gain access to visionary innovation

Wireless Patient Monitoring Technologies—Evaluation of Funding Prospects
D4AF-48

Contact:
Britni Myers
Corporate Communications – North America
P: 210.477.8481
F: 210.348.1003
E: [email protected]
Twitter: @Frost_Sullivan
Facebook: Frost & Sullivan

http://www.frost.com

SOURCE Frost & Sullivan